HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6
|
phenotype |
|
Finding
|
1
|
4
|
0.600 |
limited |
1.000 |
1 |
4
|
2016 |
2016 |
Vitamin E Assay
|
phenotype |
|
Laboratory Procedure
|
3
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Follicular cyst
|
disease |
Neoplasms
|
Acquired Abnormality
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Phencyclidine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Phencyclidine-Related Disorders
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Chronic hepatitis C virus genotype 1
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
8
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hashish Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cannabis-Related Disorder
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Pulmonary congestion
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Leydig cell tumor, benign
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Cannabis Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
19
|
8
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cholesteryl Ester Transfer Protein Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
22
|
5
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Diabetic dyslipidaemia
|
disease |
|
Disease or Syndrome
|
28
|
11
|
0.010 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
33
|
8
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cannabis Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
40
|
13
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Leydig Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
42
|
3
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Exencephaly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Congenital Abnormality
|
47
|
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Biliary calculi
|
phenotype |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Body Substance
|
48
|
31
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Bilirubin measurement
|
phenotype |
|
Laboratory Procedure
|
56
|
535
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Thyroid cancer, follicular
|
disease |
Neoplasms
|
Neoplastic Process
|
58
|
5
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Glycogen Storage Disease
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
63
|
16
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Large cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
67
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Conn Syndrome
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
82
|
25
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Premature coronary artery atherosclerosis
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
87
|
43
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Ischemic cardiomyopathy
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
110
|
5
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |